Please login to the form below

Not currently logged in
Email:
Password:

Stada

This page shows the latest Stada news and features for those working in and with pharma, biotech and healthcare.

Takeda to sell Japan consumer health unit for $2.3bn

Takeda to sell Japan consumer health unit for $2.3bn

The Japanese pharma also entered an agreement with Stada last October to divest a portfolio of select OTC drugs for a total value of $660m. ... The Stada deal includes OTC vitamins and food supplements, and select products in the cardiovascular, diabetes,

Latest news

  • GlaxoSmithKline reportedly looking to sell select antibiotic brands GlaxoSmithKline reportedly looking to sell select antibiotic brands

    GSK also sold of its 15 consumer brands to German pharma company Stada Arzneimittel AG for over 300m around the same time. ... The Stada deal was just the latest in a string of divestments – in January GSK signed a deal worth up to 955m with Bavarian

  • Takeda divests over-the-counter and prescription drugs to Stada for $660m Takeda divests over-the-counter and prescription drugs to Stada for $660m

    Japanese drug-maker Takeda has entered an agreement with German pharma Stada to divest a portfolio of select over-the-counter (OTC) and prescription drugs for a total value of $660m. . ... The portfolio of products to be divested to Stada and Acino

  • Post-merger Celgene to lead pharma growth Post-merger Celgene to lead pharma growth

    Behind Celgene is a cohort of five companies which are expected to post profit growth of 6-10%: AbbVie, AstraZeneca, Eli Lilly, Stada and Takeda.

  • Stada's €4.1bn takeover goes through Stada's €4.1bn takeover goes through

    German pharma company finally comes under new ownership. After months of wrangling, German pharma company Stada has finally come under new ownership after a successful tender by private equity firms Bain ... The buyout - which is the largest for a

  • Time running out on new Stada takeover bid Time running out on new Stada takeover bid

    Only 34% of shareholders have backed the deal so far. With a deadline looming on Wednesday, only a third of shareholders in German pharma company Stada have accepted the takeover bid ... As of Friday around 34% of Stada's shareholders had accepted, well

More from news
Approximately 10 fully matching, plus 12 partially matching documents found.

Latest Intelligence

  • Deal Watch - May 2017 Deal Watch - May 2017

    Given this background what do we make of the deal where two private equity companies, Bain and Cinven, joined forces to acquire Stada for $5.63bn? ... So why did Bain/Cinven acquire Stada at a high price? Almost certainly it was because they were in

  • Deal Watch February 2017 Deal Watch February 2017

    What is more than rumour, is the interest from several parties in acquiring the German generic company, Stada, which has pan-European capabilities and a foothold in Russia. ... Whatever happens to Stada this represents another chapter in the evolution of

  • Deal Watch table for August 2013 Deal Watch table for August 2013

    485. OptiMedica  /. Abbott. Acquisition. Ophthalmic device company. 400. Thornton &Ross /. Stada Arzneimittel. Acquisition. OTC manufacturer. 345. Endosense  /. St Jude Medical.

  • Pharma deals during August 2013 Pharma deals during August 2013

    Generics business consolidation was also evident on this side of the pond. In a defensive move the German drugmaker Stada Arzneimittel announced the $345m take-over of the UK OTC company, ... Thornton &Ross.Thornton &Ross is one of the fastest growing

  • Pharma deals during November 2012 Pharma deals during November 2012

    the subject of interest from companies such as GSK and Stada for some time. It is currently majority owned by Russia's largest drugstore chain “36.6” and has enjoyed 20

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest appointments

  • Britannia promotes Robert Wood Britannia promotes Robert Wood

    Prior to joining Britannia, which is part of Stada, in early 2011, his roles included business unit director, pharmaceuticals at International SOS and vice president of business development at Optasia Medical.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...

Infographics